Are biosimilars really cheaper?

Are biosimilars really cheaper?

Shared by:

Biologics have superior efficacy but are also expensive; this has paved way for a lucrative and rapidly expanding market for biosimilars, which are perceived to help bring down healthcare costs.
25 Mar 2017 - General
The experience in UK and also in some other European countries is very different to other parts of the world. We started using biosimilar in a big way i.e. new patients and switching existing patients in 2016. There was some resistance initially mainly from clinicians but the implementation has been smooth and without much adverse effects to patients. The savings from biosimilars are real and very large. Experience from the Scandinavian countries, where uptake of biosimilars started earlier is w...
 (Total 92 words)